C08G18/3804

Addition and condensation polymers prepared from halogenated reactants

Polymers containing halogen functionality are prepared by the addition or condensation polymerization of at least one halogenated reactant containing at least two active hydrogen-containing functional groups per molecule and at least one halogenated heteroalkyl or halogenated heteroalkenyl group per molecule and at least one co-reactant containing at least two functional groups reactive with the active hydrogen groups of the at least one halogenated reactant.

Radiopaque thermoplastic polymer

An embodiment includes a polymer composition comprising a thermoplastic polymer that: (a) is bonded to iodine, (b) includes a vinyl group, and (c) includes urethane linkages. Other embodiments are described herein.

RADIOPAQUE THERMOPLASTIC POLYMER

An embodiment includes a polymer composition comprising a thermoplastic polymer that: (a) is bonded to iodine, (b) includes a vinyl group, and (c) includes urethane linkages. Other embodiments are described herein.

ISOCYANATE-BASED FOAM AND PROCESS FOR PRODUCTION THEREOF
20220275161 · 2022-09-01 ·

There is described an isocyanate-based polymer foam having the combination of: (i) a Limiting Oxygen Index (LOI) of greater than or equal to 26.5% when measured pursuant to ASTM D2863-17a, and (ii) a Total Volatile Organic Content (TVOC) when measured pursuant to VDA 277 of less than or equal to 225 μg/g C. Preferably, the foam is produced from a foamable composition comprising: an isocyanate; a reactive compound containing: (1) at least one hydrogen which is reactive with the isocyanate, and (2) one or both of a halogen and a phosphate moiety; a blowing agent comprising one or both of water and carbon dioxide; and a catalyst; wherein the reactive compound is present in an amount in the range of from about 30% to about 95% of total ISO equivalents excluding water, if present in the foamable composition.

Drug Eluting Shape Memory Foam
20210113741 · 2021-04-22 ·

Tumor resection is commonly practiced to prevent the progression of cancer. However, there are post-surgery concerns including the formation of a void that can allow cancer cells to escape at the surgery site, which increases the risk of metastasis. To counter this challenge, an embodiment includes a polyurethane-based shape memory foam as a tissue void-filling device that can also release anti-cancer drugs. Such foams may activate at body temperature and become malleable. Such properties may enable the foam to be shaped to precisely seal the tissue void and then serve as a drug-eluting device. Based on the drug composition with poly vinyl alcohol (PVA), the drug release profile from the foam may be altered depending on the application.

ADDITION AND CONDENSATION POLYMERS PREPARED FROM HALOGENATED REACTANTS
20200299451 · 2020-09-24 ·

Polymers containing halogen functionality are prepared by the addition or condensation polymerization of at least one halogenated reactant containing at least two active hydrogen-containing functional groups per molecule and at least one halogenated heteroalkyl or halogenated heteroalkenyl group per molecule and at least one co-reactant containing at least two functional groups reactive with the active hydrogen groups of the at least one halogenated reactant.

RADIOPAQUE THERMOPLASTIC POLYMER

An embodiment includes a polymer composition comprising a thermoplastic polymer that: (a) is bonded to iodine, (b) includes a vinyl group, and (c) includes urethane linkages Other embodiments are described herein.

Drug Eluting Shape Memory Foam
20240416011 · 2024-12-19 ·

Tumor resection is commonly practiced to prevent the progression of cancer. However, there are post-surgery concerns including the formation of a void that can allow cancer cells to escape at the surgery site, which increases the risk of metastasis. To counter this challenge, an embodiment includes a polyurethane-based shape memory foam as a tissue void-filling device that can also release anti-cancer drugs. Such foams may activate at body temperature and become malleable. Such properties may enable the foam to be shaped to precisely seal the tissue void and then serve as a drug-eluting device. Based on the drug composition with poly vinyl alcohol (PVA), the drug release profile from the foam may be altered depending on the application.

Radiopaque thermoplastic polymer

An embodiment includes a polymer composition comprising a thermoplastic polymer that: (a) is bonded to iodine, (b) includes a vinyl group, and (c) includes urethane linkages. Other embodiments are described herein.